CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles
about
DNA vaccine that targets hemagglutinin to MHC class II molecules rapidly induces antibody-mediated protection against influenza.Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumorBaculovirus capsid display potentiates OVA cytotoxic and innate immune responses.The specificity of targeted vaccines for APC surface molecules influences the immune response phenotype.Immunotherapy for polyomaviruses: opportunities and challenges.A simple, clinically relevant therapeutic vaccine shows long-term protection in an aggressive, delayed-treatment B lymphoma model.
P2860
CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
CD4+ and CD8+ T cells can act ...... Her2/neu virus-like particles
@ast
CD4+ and CD8+ T cells can act ...... Her2/neu virus-like particles
@en
type
label
CD4+ and CD8+ T cells can act ...... Her2/neu virus-like particles
@ast
CD4+ and CD8+ T cells can act ...... Her2/neu virus-like particles
@en
prefLabel
CD4+ and CD8+ T cells can act ...... Her2/neu virus-like particles
@ast
CD4+ and CD8+ T cells can act ...... Her2/neu virus-like particles
@en
P2093
P2860
P1433
P1476
CD4+ and CD8+ T cells can act ...... Her2/neu virus-like particles
@en
P2093
Kalle Andreasson
Karin Tegerstedt
Mathilda Eriksson
Tina Dalianis
Torbjörn Ramqvist
P2860
P304
P356
10.1371/JOURNAL.PONE.0011580
P407
P577
2010-07-19T00:00:00Z